Medicus Pharma Ltd.MDCXWEarnings & Financial Report
Nasdaq
NextFeb 27, 2026
MDCXW Q3 2025 Key Financial Metrics
Revenue
$11.6K
Gross Profit
N/A
Operating Profit
$-15
Net Profit
$-20.9M
Gross Margin
N/A
Operating Margin
-0.1%
Net Margin
-180917.3%
YoY Growth
-79.2%
EPS
$-1.12
Financial Flow
Medicus Pharma Ltd. Q3 2025 Financial Summary
Medicus Pharma Ltd. reported revenue of $11.6K for Q3 2025, with a net profit of $-20.9M (-180917.3% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $11.6K |
|---|---|
| Net Profit | $-20.9M |
| Gross Margin | N/A |
| Operating Margin | -0.1% |
| Report Period | Q3 2025 |
Income Statement
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Revenue | $-79025 | $55514 | $40004 | $11572 |
| YoY Growth | N/A | N/A | 150.6% | -79.2% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Assets | N/A | N/A | $11.9M | $10.0M |
| Liabilities | N/A | N/A | $8.7M | $10.8M |
| Equity | $7.1M | $4.8M | $3.2M | $-910126 |
Cash Flow
| Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|
| Operating CF | $-3.1M | $-5.5M | $-6.8M |